Article Text
PDFClinical ethics
How tall is too tall? On the ethics of oestrogen treatment for tall girls
Abstract
Oestrogen treatment for girls, to prevent psychosocial problems due to extreme tallness, has been available for almost 50 years but uncertainty about its position prevails. The ethical problems of this treatment are focused on in this paper. After a brief overview on historical and medical aspects, ethical issues such as the general justification of oestrogen treatment, evaluation of its success and ethical concerns related to research in this subject are dealt with in detail.
Statistics from Altmetric.com
Footnotes
-
Competing interests: None.
Read the full text or download the PDF:
Other content recommended for you
- Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5–8.5 years
- Oestrogen treatment of constitutional tall stature: a risk-benefit ratio
- Medical intervention in a constitutionally tall child
- On the ethics of oestrogen treatment for tall girls: an update
- Effect of oxandrolone and timing of pubertal induction on final height in Turner’s syndrome: randomised, double blind, placebo controlled trial
- A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis
- Investigation and management of tall stature
- Long-term follow-up after bilateral percutaneous epiphysiodesis around the knee to reduce excessive predicted final height
- Why give a child growth hormone?
- Overgrowth